External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations
Next-generation sequencing (NGS) is likely to become the new standard method for HIV drug resistance (HIVDR) genotyping. Despite the significant advances in the development of wet-lab protocols and bioinformatic data processing pipelines, one often-missing critical component of an NGS HIVDR assay fo...
Main Authors: | Hezhao Ji, Neil Parkin, Feng Gao, Thomas Denny, Cheryl Jennings, Paul Sandstrom, Rami Kantor |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/5/556 |
Similar Items
-
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
by: Cheryl Jennings, et al.
Published: (2020-12-01) -
Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing
by: Marc Noguera-Julian, et al.
Published: (2020-06-01) -
External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges
by: Emma R. Lee, et al.
Published: (2020-05-01) -
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
by: Santiago Ávila-Ríos, et al.
Published: (2020-06-01) -
Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays
by: Michael G. Becker, et al.
Published: (2020-06-01)